title: Molecular characterisation and cetuximab-based treatment in a patient with refractory small bowel adenocarcinoma.
authors: Sara
authors: S
authors: De Dosso
authors: Francesca
authors: F
authors: Molinari
authors: Vittoria
authors: V
authors: Martin
authors: Milo
authors: M
authors: Frattini
authors: Piercarlo
authors: P
authors: Saletti
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D017809:Fatal Outcome; D006801:Humans; D007078:Ileal Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab